Definition
reduction in the concentration of transferrin that is not saturated (bound) with iron; this represents the reserve capacity of transferrin and is often measured by the Unsaturated Iron Binding Capacity (UIBC) test
0%
of tested genes
0
significant genes
0
tested genes
IMPC Gene variants with decreased circulating unsaturated transferrin level
Total number of significant genotype-phenotype associations: 6
| Gene / Allele | Zygosity | Sex | Life Stage | Phenotype | Parameter | Phenotyping Center |
P Value |
|---|---|---|---|---|---|---|---|
| Pkn2 Pkn2tm1b(KOMP)Wtsi |
HET | Early adult | decreased circulating unsaturated transferrin level | UIBC (unsaturated iron binding capacity) Clinical Chemistry |
HMGU IMPC |
1.18×10-07 | |
| Ldlr Ldlrtm1b(EUCOMM)Wtsi |
HOM | Early adult | decreased circulating unsaturated transferrin level | UIBC (unsaturated iron binding capacity) Clinical Chemistry |
HMGU IMPC |
2.60×10-06 | |
| Lrp1b Lrp1bem1(IMPC)Hmgu |
HET | Early adult | decreased circulating unsaturated transferrin level | UIBC (unsaturated iron binding capacity) Clinical Chemistry |
HMGU IMPC |
3.49×10-05 | |
| Wars1 Wars1tm1b(EUCOMM)Hmgu |
HET | Early adult | decreased circulating unsaturated transferrin level | UIBC (unsaturated iron binding capacity) Clinical Chemistry |
HMGU IMPC |
3.83×10-05 | |
| Oplah Oplahtm1b(KOMP)Wtsi |
HOM | Early adult | decreased circulating unsaturated transferrin level | UIBC (unsaturated iron binding capacity) Clinical Chemistry |
HMGU IMPC |
7.15×10-05 |